Cynthia S. Crowson

Cynthia S. Crowson

Auto-generated profile, based on publicly available information

Cynthia S. Crowson

Division of Rheumatology Mayo Clinic Rochester Minnesota

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2016 in Statistical Methods in Medical Research
Verified
Journal Article
Open access
PDF file
CCCynthia S Crowson
Cynthia S Crowson
EAElizabeth J Atkinson
Elizabeth J Atkinson
TTTerry M Therneau
Terry M Therneau
Current methods used to assess calibration are limited, particularly in the assessment of prognostic models. Methods for testing and visualizing calibration (e.g. the Hosmer–Lemeshow test and calibration slope) have been well thought out in the binary regression setting. However, extension of these methods to Cox models is less well known and could be improved. We describe a model-based framework for the assessment of calibration in the binary setting that provides natural extensions to the survival data setting. We show that Poisson regression models can be used to easily assess calibration in prognostic models. In addition, we show that a calibration test suggested for use in survival data has poor performance. Finally, we apply these methods to the problem of external validation of a risk score developed for the general population when assessed in a special patient population (i.e. patients with particular comorbidities, such as rheumatoid arthritis).

8 April 2019 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
PDF file
ADAli Duarte‐García
Ali Duarte‐García
MPMichael M. Pham
Michael M. Pham
CCCynthia S. Crowson
Cynthia S. Crowson
SAShreyasee Amin
Shreyasee Amin
KMKevin G. Moder
Kevin G. Moder
EMEric. L. Matteson
Eric. L. Matteson

1 January 2018 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
CCCynthia S Crowson
Cynthia S Crowson
SRSilvia Rollefstad
Silvia Rollefstad
EIEirik Ikdahl
Eirik Ikdahl
GKGeorge D Kitas
George D Kitas
PRPiet L C M van Riel
Piet L C M van Riel
ASAnne Grete Semb
Anne Grete Semb
Objectives Patients with rheumatoid arthritis (RA) have an excess risk of cardiovascular disease (CVD). We aimed to assess the impact of CVD risk factors, including potential sex differences, and RA-specific variables on CVD outcome in a large, international cohort of patients with RA. Methods In 13 rheumatology centres, data on CVD risk factors and RA characteristics were collected at baseline. CVD outcomes (myocardial infarction, angina, revascularisation, stroke, peripheral vascular disease and CVD death) were collected using standardised definitions. Results 5638 patients with RA and no prior CVD were included (mean age: 55.3 (SD: 14.0) years, 76% women). During mean follow-up of 5.8 (SD: 4.4) years, 148 men and 241 women developed a CVD event (10-year cumulative incidence 20.9% and 11.1%, respectively). Men had a higher burden of CVD risk factors, including increased blood pressure, higher total cholesterol and smoking prevalence than women (all p<0.001). Among the traditional CVD risk factors, smoking and hypertension had the highest population attributable risk (PAR) overall and among both sexes, followed by total cholesterol. The PAR for Disease Activity Score and for seropositivity were comparable in magnitude to the PAR for lipids. A total of 70% of CVD events were attributable to all CVD risk factors and RA characteristics combined (separately 49% CVD risk factors and 30% RA characteristics). Conclusions In a large, international cohort of patients with RA, 30% of CVD events were attributable to RA characteristics. This finding indicates that RA characteristics play an important role in efforts to reduce CVD risk among patients with RA.

1 August 2012 in The American Journal of Cardiology
Verified
Journal Article
Closed access
CCCynthia S. Crowson
Cynthia S. Crowson
EMEric L. Matteson
Eric L. Matteson
VRVeronique L. Roger
Veronique L. Roger
TTTerry M. Therneau
Terry M. Therneau
SGSherine E. Gabriel
Sherine E. Gabriel

1 April 2020 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
EMElena Myasoedova
Elena Myasoedova
JDJohn Davis
John Davis
EMEric L Matteson
Eric L Matteson
CCCynthia S Crowson
Cynthia S Crowson
Objectives To examine trends in the incidence of rheumatoid arthritis (RA) from 2005 to 2014 overall and by serological status as compared with 1995–2004 and 1985–1994. Methods We evaluated RA incidence trends in a population-based inception cohort of individuals aged ≥18 years who first fulfilled the 1987 American College of Rheumatology (ACR) criteria for RA between 1 January 1985 and 31 December 2014. Incidence rates were estimated and were age-adjusted and sex-adjusted to the white population in the USA in 2010. Trends in incidence were examined using Poisson regression methods. Results The 2005–2014 incidence cohort comprised 427 patients: mean age 55.4 years, 68% female, 51% rheumatoid factor (RF) positive and 50% anti-cyclic citrullinated peptide antibody positive. The overall age-adjusted and sex-adjusted annual RA incidence in 2005–2014 was 41/100 000 population (age-adjusted incidence: 53/100 000 in women and 29/100 000 in men). While these estimates were similar to the 1995–2004 decade, there was a decline in the incidence of RF-positive RA in 2005–2014 compared with the previous two decades (p=0.004), with a corresponding increase in RF-negative cases (p<0.001). Smoking rates declined and obesity rates increased from earlier decades to more recent years. Conclusions Significant increase in incidence of RF-negative RA and decrease in RF-positive RA in 2005–2014 compared with previous decades was found using 1987 ACR criteria. The incidence of RA overall during this period remained similar to the previous decade. The changing prevalence of environmental factors, such as smoking, obesity and others, may have contributed to these trends. Whether these trends represent a changing serological profile of RA requires further investigation.

3 June 2020 in Nature Reviews Rheumatology
Verified
Journal Article
Closed access
PDF file
ASAnne Grete Semb
Anne Grete Semb
EIEirik Ikdahl
Eirik Ikdahl
GWGrunde Wibetoe
Grunde Wibetoe
CCCynthia Crowson
Cynthia Crowson
SRSilvia Rollefstad
Silvia Rollefstad